Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial
Lynch syndrome (LS) is the most common cause of inherited colorectal cancer (CRC) and confers a high lifetime risk of CRC estimated to be up to 60%. Colonoscopy is recommended every 2 years in LS patients abov...
Source: Trials - Category: General Medicine Authors: Adil Soualy, David Deutsch, Mourad Benallaoua, Amal Ait-Omar, Florence Mary, Sabine Helfen, Marouane Boubaya, Vincent Levy and Robert Benamouzig Tags: Study protocol Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Colonoscopy | Colorectal Cancer | General Medicine | HNPCC | Lynch Syndrome | Study